motilium
jntl consumer health (new zealand) limited - domperidone 10mg; - tablet - 10 mg - active: domperidone 10mg excipient: cottonseed oil, hydrogenated hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone purified water sodium laurilsulfate starch - adults and adolescents weighing 35kg or more: symptomatic treatment of the dyspeptic symptom complex that may be associated with delayed gastic emptying such as epigastric sense of fullness, abdominal distension or swelling, or epigastric pain or discomfort.
sensipar
amgen new zealand limited - cinacalcet hydrochloride 33mg (r - enantiomer, anhydrate, equivalent to 30mg cinacalcet as the free base) - film coated tablet - 30 mg - active: cinacalcet hydrochloride 33mg (r - enantiomer, anhydrate, equivalent to 30mg cinacalcet as the free base) excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry clear ys-1-19025-a opadry green povidone starch - sensipar may be used to treat the biochemical manifestations of secondary hyperparathyroidism in adult patients with end stage renal disease, receiving dialysis. sensipar should be used as adjunctive therapy.
sensipar
amgen new zealand limited - cinacalcet hydrochloride 66mg (r - enantiomer, anhydrate, equivalent to 60mg cinacalcet as the free base) - film coated tablet - 60 mg - active: cinacalcet hydrochloride 66mg (r - enantiomer, anhydrate, equivalent to 60mg cinacalcet as the free base) excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry clear ys-1-19025-a opadry green povidone starch - sensipar may be used to treat the biochemical manifestations of secondary hyperparathyroidism in adult patients with end stage renal disease, receiving dialysis. sensipar should be used as adjunctive therapy.
sensipar
amgen new zealand limited - cinacalcet hydrochloride 99mg (r - enantiomer, anhydrate, equivalent to 90mg cinacalcet as the free base) - film coated tablet - 90 mg - active: cinacalcet hydrochloride 99mg (r - enantiomer, anhydrate, equivalent to 90mg cinacalcet as the free base) excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry clear ys-1-19025-a opadry green povidone starch - sensipar may be used to treat the biochemical manifestations of secondary hyperparathyroidism in adult patients with end stage renal disease, receiving dialysis. sensipar should be used as adjunctive therapy.
tobi podhaler
viatris limited - tobramycin 28mg - powder filled inhalation capsule - 28 mg - active: tobramycin 28mg excipient: butyl alcohol calcium chloride dihydrate carnauba wax carrageenan distearoyl-dl-phosphatidylcholine hypromellose indigo carmine aluminium lake isopropyl alcohol potassium chloride propylene glycol shellac sulfuric acid titanium dioxide water for injection - management of cystic fibrosis patients with pseudomonas aeruginosa infections.
norvasc odt (orodispersible tablet) 10mg
pfizer pfe private limited - amlodipine besylate 13.86mg eqv amlodopine - tablet, orally disintegrating - 10mg - amlodipine besylate 13.86mg eqv amlodopine 10mg
norvasc odt (orodispersible tablet) 5mg
pfizer pfe private limited - amlodipine besylate 6.93mg eqv amlodipine - tablet, orally disintegrating - 5mg - amlodipine besylate 6.93mg eqv amlodipine 5mg
zoledronic acid accord 4 mg/5 ml concentrate for solution for infusion
accord healthcare limited - zoledronic acid monohydrate - concentrate for solution for infusion - 4 mg/5 ml concentrate - hypercalcemia cancer, bone fractures - drug affecting bone structure and mineralization, bisphosphonates - prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. treatment of adult patients with tumour-induced hypercalcaemia (tih).
fycompa 2 mg film-coated tablets
eisai europe limited - perampanel - film-coated tablet - 2 mg - epilepsies, partial - antiepileptics, other antiepileptics - indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older
fycompa 4 mg film-coated tablets
eisai europe limited - perampanel - film-coated tablets - 4 mg - epilepsies, partial - antiepileptics, other antiepileptics - indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older